Literature DB >> 22527502

Circulating microRNAs as noninvasive biomarkers in breast cancer.

Maria Angelica Cortez1, James William Welsh, George Adrian Calin.   

Abstract

MicroRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these non-coding RNAs can modulate the expression of more than half the protein-coding genes in mammalian genomes. MiRNAs play important regulatory roles in a variety of cellular functions and in several diseases, including cancer. Aberrant miRNA expression has been well characterized in cancer, with implications for progression and prognosis. Recently, the discovery of miRNAs in body fluids, such as serum and plasma, opens up the possibility of using them as noninvasive biomarkers of disease and therapy response. In this chapter, we discuss the use of circulating miRNAs as biomarkers of disease and therapy response and as diagnostic and prognostic markers in breast cancer. We also discuss the main issues related to establishing circulating miRNAs as biomarkers in cancer.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22527502      PMCID： PMC3855311          DOI： 10.1007/978-3-642-28160-0_13

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  55 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  A truth serum for cancer--microRNAs have major potential as cancer biomarkers.

Authors:  Lena J Chin; Frank J Slack
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

4.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.

Authors:  Fengjun Wang; Zhiguo Zheng; Jiangfeng Guo; Xianfeng Ding
Journal:  Gynecol Oncol       Date:  2010-12       Impact factor: 5.482

6.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Authors:  Mattia Boeri; Carla Verri; Davide Conte; Luca Roz; Piergiorgio Modena; Federica Facchinetti; Elisa Calabrò; Carlo M Croce; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

7.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

8.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

9.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

10.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824
View more
  43 in total

Review 1.  The roles of microRNAs on tuberculosis infection: meaning or myth?

Authors:  Harapan Harapan; Fitra Fitra; Ichsan Ichsan; Mulyadi Mulyadi; Paolo Miotto; Nabeeh A Hasan; Marta Calado; Daniela M Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2013-08-15       Impact factor: 3.131

2.  Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

Authors:  Ebru Esin Yoruker; Fatma Aydoğan; Uğur Gezer; Pinar Saip; Nejat Dalay
Journal:  Mol Clin Oncol       Date:  2015-05-13

3.  Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.

Authors:  Hailing Liu; Yan Wang; Xin Li; Yan-jun Zhang; Jie Li; Yi-qiong Zheng; Mei Liu; Xin Song; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-22

4.  Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.

Authors:  Ying Li; Mei Liu; Yanjun Zhang; Chun Han; Junhao You; Junlan Yang; Cheng Cao; Shunchang Jiao
Journal:  Tumour Biol       Date:  2013-06-26

5.  Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts.

Authors:  Hao Hu; Yi Zhang; Xian-Hua Cai; Ji-Feng Huang; Lin Cai
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

6.  microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.

Authors:  Chin-Wen Chang; Hui-Chen Wu; Mary Beth Terry; Regina M Santella
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

7.  Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.

Authors:  En-hai Cui; Hong-jiao Li; Feng Hua; Bin Wang; Wei Mao; Xue-ren Feng; Jian-you Li; Xiang Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

Review 8.  Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Authors:  Andrea Ravelli; James M Reuben; Francesco Lanza; Simone Anfossi; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Paola Brambilla; Manuela Milani; Daniele Spada; Paolo Pedrazzoli; Massimo Martino; Alberto Bottini; Daniele Generali
Journal:  Tumour Biol       Date:  2015-08-26

Review 9.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

Review 10.  Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?

Authors:  Gerasimos Socrates Christodoulatos; Maria Dalamaga
Journal:  World J Clin Oncol       Date:  2014-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.